Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort.
Naitoh I, Kamisawa T, Tanaka A, Nakazawa T, Kubota K, Takikawa H, Unno M, Masamune A, Kawa S, Nakamura S, Okazaki K; collaborators. Naitoh I, et al. Among authors: nakamura s. Dig Liver Dis. 2021 Oct;53(10):1308-1314. doi: 10.1016/j.dld.2021.02.009. Epub 2021 Mar 2. Dig Liver Dis. 2021. PMID: 33664004
Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma-Cooling effect by endoscopic nasobiliary drainage tube.
Ogawa T, Kawamoto H, Kobayashi Y, Nakamura S, Miyatake H, Harada R, Tsutsumi K, Fujii M, Kurihara N, Kato H, Hirao K, Mizuno O, Ishida E, Okada H, Yamamoto K. Ogawa T, et al. Among authors: nakamura s. Eur J Radiol. 2010 Feb;73(2):385-90. doi: 10.1016/j.ejrad.2008.10.021. Epub 2008 Dec 3. Eur J Radiol. 2010. PMID: 19056192 Clinical Trial.
Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina S, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K. Matsubara M, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2012 Oct;27(10):1602-8. doi: 10.1111/j.1440-1746.2012.07173.x. J Gastroenterol Hepatol. 2012. PMID: 22554292 Free article.
Diagnostic usefulness of precise examinations with intraductal ultrasonography, peroral cholangioscopy and laparoscopy of immunoglobulin G4-related sclerosing cholangitis.
Horiguchi S, Ikeda F, Shiraha H, Yamamoto N, Sakakihara I, Noma Y, Tsutsumi K, Kato H, Hagihara H, Yasunaka T, Nakamura S, Kobashi H, Kawamoto H, Yamamoto K. Horiguchi S, et al. Among authors: nakamura s. Dig Endosc. 2012 Sep;24(5):370-3. doi: 10.1111/j.1443-1661.2012.01300.x. Dig Endosc. 2012. PMID: 22925292
Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: nakamura s. Oncol Rep. 2016 May;35(5):2576-82. doi: 10.3892/or.2016.4681. Epub 2016 Mar 16. Oncol Rep. 2016. PMID: 26985715 Free PMC article.
[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: nakamura s. Oncol Rep. 2017 Mar;37(3):1921. doi: 10.3892/or.2017.5419. Epub 2017 Feb 3. Oncol Rep. 2017. PMID: 28184917 Free PMC article.
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y. Tada T, et al. Among authors: nakamura s. Liver Int. 2020 Apr;40(4):968-976. doi: 10.1111/liv.14405. Epub 2020 Mar 1. Liver Int. 2020. PMID: 32064740
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
Hiraoka A, Kumada T, Kariyama K, Tada T, Tani J, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Kawata K, Yasuda S, Toyoda H, Ohama H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Michitaka K, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2021 Jul;36(7):1812-1819. doi: 10.1111/jgh.15336. Epub 2020 Nov 29. J Gastroenterol Hepatol. 2021. PMID: 33171524 Free PMC article.
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
Hiraoka A, Kumada T, Tada T, Kariyama K, Tani J, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Kawata K, Yasuda S, Toyoda H, Ohama H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Michitaka K, Hiasa Y, Kudo M. Hiraoka A, et al. Among authors: nakamura s. Liver Cancer. 2021 Apr;10(2):115-125. doi: 10.1159/000513355. Epub 2021 Feb 25. Liver Cancer. 2021. PMID: 33977088 Free PMC article.
11,169 results
You have reached the last available page of results. Please see the User Guide for more information.